Beáta Biri-Kovács

Biri-Kovács, Beáta, Zoltán Bánóczi, Anitha Tummalapally, and Ildikó Szabó. 2023. “Peptide Vaccines In Melanoma: Chemical Approaches Towards Improved Immunotherapeutic Efficacy”. Pharmaceutics 15 (2). MDPI AG: 452. doi:10.3390/pharmaceutics15020452.

Horváti, Kata, Kinga Fodor, Bernadett Pályi, Judit Henczkó, Gyula Balka, Gergő Gyulai, Éva Kiss, Beáta Biri-Kovács, Zsuzsanna Senoner, and Szilvia Bősze. 2021. “Novel Assay Platform To Evaluate Intracellular Killing Of Mycobacterium Tuberculosis: In Vitro And In Vivo Validation”. Frontiers In Immunology 12. Frontiers Media SA. doi:10.3389/fimmu.2021.750496.

Pári, Edit, Kata Horváti, Szilvia Bősze, Beáta Biri-Kovács, Bálint Szeder, Ferenc Zsila, and Éva Kiss. 2020. “Drug Conjugation Induced Modulation Of Structural And Membrane Interaction Features Of Cationic Cell-Permeable Peptides”. International Journal Of Molecular Sciences 21: 2197. doi:10.3390/ijms21062197.

Quemé-Peña, Mayra, Maria Ricci, Tünde Juhász, Kata Horváti, Szilvia Bősze, Beáta Biri-Kovács, Bálint Szeder, Ferenc Zsila, and Tamás Beke-Somfai. 2020. “Old Polyanionic Drug Suramin Suppresses Detrimental Cytotoxicity Of The Host Defense Peptide Ll-37”. Acs Pharmacology & Translational Science. doi:10.1021/acsptsci.0c00155.

Bősze, Szilvia, Ferenc Zsila, Beáta Biri-Kovács, Bálint Szeder, Zsuzsa Majer, Ferenc Hudecz, and Katalin Uray. 2020. “Tailoring Uptake Efficacy Of Hsv-1 Gd Derived Carrier Peptides”. Biomolecules 10: 721. doi:10.3390/biom10050721.